Northern Trust Corp Paratek Pharmaceuticals, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$1.52 - $2.8 $2,693 - $4,961	1,772 Added 1.57%	114,434 $252,000
Q1 2023 May 15, 2023	BUY	$1.37 - $2.54 $2,731 - $5,064	1,994 Added 1.8%	112,662 $286,000
Q4 2022 Feb 13, 2023	SELL	$1.67 - $2.51 $960 - $1,443	-575 Reduced 0.52%	110,668 $206,000
Q3 2022 Nov 14, 2022	BUY	$1.96 - $2.93 $6,910 - $10,331	3,526 Added 3.27%	111,243 $286,000
Q2 2022 Aug 12, 2022	SELL	$1.73 - $3.09 $591,002 - $1.06 Million	-341,620 Reduced 76.03%	107,717 $208,000
Q1 2022 May 13, 2022	SELL	$2.94 - $4.77 $51,332 - $83,284	-17,460 Reduced 3.74%	449,337 $1.34 Million
Q4 2021 Feb 08, 2022	SELL	$4.07 - $5.3 $301 - $392	-74 Reduced 0.02%	466,797 $2.1 Million
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $66,697 - $102,742	-14,191 Reduced 2.95%	466,871 $2.27 Million
Q2 2021 Aug 13, 2021	SELL	$6.81 - $10.93 $35,602 - $57,142	-5,228 Reduced 1.08%	481,062 $3.28 Million
Q1 2021 May 12, 2021	SELL	$6.14 - $8.31 $286,504 - $387,761	-46,662 Reduced 8.76%	486,290 $3.43 Million
Q4 2020 Feb 11, 2021	SELL	$4.58 - $7.14 $27,411 - $42,732	-5,985 Reduced 1.11%	532,952 $3.34 Million
Q3 2020 Nov 16, 2020	SELL	$4.19 - $6.69 $81,457 - $130,060	-19,441 Reduced 3.48%	538,937 $2.92 Million
Q2 2020 Aug 14, 2020	BUY	$2.97 - $5.22 $398,680 - $700,711	134,236 Added 31.65%	558,378 $2.91 Million
Q1 2020 May 14, 2020	BUY	$2.67 - $4.97 $67,663 - $125,949	25,342 Added 6.35%	424,142 $1.34 Million
Q4 2019 Feb 14, 2020	SELL	$2.93 - $4.5 $80,835 - $124,150	-27,589 Reduced 6.47%	398,800 $1.61 Million
Q3 2019 Nov 13, 2019	BUY	$3.08 - $5.76 $37,037 - $69,264	12,025 Added 2.9%	426,389 $1.84 Million
Q2 2019 Aug 13, 2019	BUY	$3.47 - $6.32 $15,673 - $28,547	4,517 Added 1.1%	414,364 $1.65 Million
Q1 2019 May 13, 2019	SELL	$5.36 - $7.24 $16,449 - $22,219	-3,069 Reduced 0.74%	409,847 $2.2 Million
Q4 2018 Feb 12, 2019	SELL	$4.8 - $11.6 $92,035 - $222,418	-19,174 Reduced 4.44%	412,916 $2.12 Million
Q3 2018 Nov 14, 2018	BUY	$9.05 - $10.95 $210,358 - $254,521	23,244 Added 5.69%	432,090 $4.19 Million
Q2 2018 Sep 18, 2018	SELL	$10.2 - $13.9 $18,788 - $25,603	-1,842 Reduced 0.45%	408,846 $4.17 Million
Q2 2018 Aug 14, 2018	BUY	$10.2 - $13.9 $502,676 - $685,019	49,282 Added 13.64%	410,688 $4.19 Million
Q1 2018 May 09, 2018	BUY	$12.65 - $18.85 $526,341 - $784,310	41,608 Added 13.01%	361,406 $4.7 Million
Q4 2017 Feb 14, 2018	SELL	$17.45 - $25.6 $136,441 - $200,166	-7,819 Reduced 2.39%	319,798 $5.73 Million
Q3 2017 Nov 13, 2017	BUY	$18.9 - $28.2 $6.19 Million - $9.24 Million	327,617	327,617 $8.22 Million

Others Institutions Holding PRTK

# of Institutions

Shares Held

1.54M

Call Options Held

Put Options Held

View Full List

About Paratek Pharmaceuticals, Inc.

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

More about PRTK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account